with deep experience in Ai, immunology, synthetic biology, and protein expression
from strategic partnerships to internal pipeline candidates as of 3/31/2023
of state-of-the-art wet labs in Vancouver WA, advanced Ai Research in NYC, and a Drug Innovation Center in Zug Switzerland
High quality, high-throughput protein-protein interaction data generated weekly
What if there was a better way to create new drugs? A faster way that could bring better medicines to patients sooner? Not chemical drugs, but antibody drugs that tap our natural immune defenses?
From a basement in Portland, Oregon, we engineered biotech's workhorse organism E. coli to produce full-length antibodies - an industry first. But we didn't stop there. Now we're the first to use zero-shot generative Ai to design and validate de novo antibody candidates, potentially reducing by >50% the time to get new drug leads into the clinic - while also increasing their probability of success.
What the world has been seeing over the last few months with the power of generative Ai has been central to Absci's vision for years. Instead of looking for drugs like a needle in a haystack, we create them in silico using generative Ai.
Screening billions of cells each week, going from Ai-designed antibodies to wet lab-validated candidates in about six weeks. While generative Ai is the latest buzz, we've been perfecting this solution for over 10 years.
Our vision is to deliver breakthrough therapeutics at the click of a button, for everyone. We are unlocking the potential of next-generation biologics by harnessing deep learning Ai and synthetic biology to explore a vast therapeutic sequence space inaccessible to conventional discovery methods.
From the beginning, we set our sights on the seemingly impossible, and we won't settle until we get there. It will take a state-of-the-art wet lab, artificial Intelligence, and above all else a team of brilliant Unlimiters from a variety of disciplines, from synbio and pharma to biotech and Ai, to achieve our vision. We are gritty, creative, and we are pushing the limits of science in a way that no one has done before because that's how we will save lives.